News

Berdazimer gel, 10.3% demonstrated positive, topline data in the phase 3 randomized clinical B-SIMPLE4 trial (NCT04535531) that featured a total of 891 patients aged 6 months or older who had 3 to 709 raised molluscum contagiosum lesions.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

In the final installment of our RSV Roundtable video series, our panel breaks down the importance of discussing new immunizations with patients now, and how crucial they will be in future RSV seasons.

Biopharmaceutical company, Invivyd, made the request to the FDA for its investigational antibody, VYD222.

Results demonstrated that caregiver burden scored a 2.14 on the caregiver burden scale, which is within the average burden level, though a higher burden of care is associated with a higher sense of loneliness. These results can help health care professionals develop a family-centered treatment plan.

A recent study by the CDC indicates differing rates of breastfeeding initiation among various racial and ethnic groups, underscoring the significance of meticulous data disaggregation for precise insights into public health.

New neonatal incubators from Drager and certain GE Healthcare incubators do not need to be run for a week prior to clinical use, according to a healthcare provider update from the FDA.

William Gallentine, DO, explains why he is excited for the year ahead when it comes to epilepsy treatment as new technologies emerge and the treatment landscape changes.

According to a recent study, young adults (aged 18-19 years) discontinue ADHD medication the most, compared to younger children.

More than 675,000 cans of specialty infant formula for cow’s milk allergy have been voluntarily recalled by Reckitt/Mead Johnson Nutrition because of a possible contamination with Cronobacter sakazakii.

A discussion of the intense 2023 RSV season, approved treatment tools, and an outlook for 2024.

In the fourth installment of RSV Roundtable, our panel explains the challenges in protecting the senior population against RSV.

Candice Jones, MD, shares what she wants to continue into the new year when it comes to pediatric health care.

With useful tips from the American Academy of Pediatrics, parents can ring in 2024 the right way, with healthy digital habits, increased reading, and more family activities to benefit their children.

Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses vaccine hesitancy and hopes to increase vaccination for preventable diseases in 2024.

Smartphone applications to estimate bilirubin levels correlate reasonably well with serum bilirubin levels, according to a meta-analysis of 14 studies.

Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, offers her perspective on the latest articles from the November/December issue of Contemporary Pediatrics.

In the third installment of RSV Roundtable, our panel discusses the impact nirsevimab has had this RSV season.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

A study in the European Journal of Medical Research revealed that higher maternal study satisfaction, older maternal age, and paternal participation were linked to better compliance in visits for children at risk of type 1 diabetes.

A 4-day-old boy with a midline neck lesion was born at term by normal vaginal delivery. After birth, the midline lesion had the configuration of a linear cleft with a cephalocaudal orientation, extending from the level below the hyoid bone to the suprasternal notch, with a length of 2.5 cm and a width of 0.5 cm. What's the diagnosis?

William Gallentine, DO, explains the initial signs of pediatric seizures and epilepsy and how pediatricians can point them out, all while reassuring parents and determining proper care.

A new systematic review and meta-analysis found that the risk of type 2 diabetes decreased significantly at walking speeds of 4 km/h or above.

Birch triterpenes (FILSUVEZ; Chiesi Global Rare Diseases) is the first approved treatment for wounds associated with junctional epidermolysis bullosa (JEB), according to the developer.

The study evaluated whether fetuses with Down syndrome and normal obstetric ultrasounds (OB-USs) had missed diagnoses of critical congenital heart disease (CHD) by conducting a retrospective review.

In a recent phase 3 trial, omalizumab (Xolair; Genentech) led to children and adolescents being able to receive higher doses of common foods without allergic reactions.

Mothers with mood disorders—either bipolar disorder, major depressive disorder— or schizophrenia/ schizoaffective disorder are not associated with their offspring’s risk for type 1 diabetes, according to a recent study.

A lead study investigator highlights epicutaneous immunotherapy using DBV 712 (Viaskin Peanut; DBV Technologies), its study details, and breaks down its usability, indications, and treatment potential.